Drug Type Interleukins, Biosimilar |
Synonyms Oprelvekin Biosimilar (Beijing SL Pharmaceutical Co., Ltd.), Recombinant Human Interleukin-11, 奥普瑞白介素生物类似药(北京双鹭药业股份有限公司) + [2] |
Target |
Action stimulants |
Mechanism IL-11RA stimulants(Interleukin 11 receptor alpha stimulants), Thrombopoiesis stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (17 Mar 2003), |
Regulation- |

| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Thrombocytopenia | China | 17 Mar 2003 |






